Breast Cancer
National Comprehensive Cancer Network updates breast cancer guidelines
Published in Lab Business Week, January 14th, 2007
These changes highlight leading developments in the treatment of breast cancer and represent the recognized standard for clinical policy in oncology in both the community and the academic practice settings.
Based on results from the study of Tamoxifen and Raloxifene (STAR) trial, a panel of added Raloxifene (Evista, Eli Lilly and Company) as an option for reducing the risk of invasive breast cancer in postmenopausal women with lobular carcinoma in situ.
The accuracy of HER2 assays...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-01-14)
More Articles from Lab Business Week
- Antisense Technology
Research from Abbott Laboratories in antisense technology provides new insights - Business Update
Barr confirms generic Thalomid capsule application - Business Update
Paladin, Auxilium sign exclusive distribution agreement for Testim - Cell Biology
Cold Spring Harbor Laboratory describes research in cell biology - Depression
New findings from Pelvipharm Laboratories in the area of depression published - Depression
Research findings from Cold Spring Harbor Laboratory update understanding of depression - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
